Live Markets
Tuesday, October 27, 2026·George Town, KY·29°·Partly Cloudy
Markets Open · NYSE·Newsletter·Masthead·
VOL. XII · NO. 117Established MMXIV · George Town, Grand CaymanAtlantic Edition · $4.50

The Cayman Journal

Finance · Business · Technology · Caribbean & Global Affairs
Markets · Healthcare

ProtoKinetix, Incorporated (PKTX)

PNK · Biotechnology

$0.000.00 (0.00%)Quote refreshed

Sources: Yahoo Finance (quote, statistics) · SEC EDGAR (filings, insider trades, 13F holders) · company filings & press wires

Market Cap
$123,489
P/E (TTM)
—
EPS
—
Div Yield
—
52W Range
$0.00–$0.01
Beta
0.98

Company overview

ProtoKinetix, Incorporated, a research and development stage bio-technology company, focuses on the scientific medical research of anti-freeze glycoproteins (AFGPs) or anti-aging glycoproteins (AAGPs). Its AFGPs are used in various commercial applications, such as targeted health care solutions, as well as AAGPs are used in ophthalmology, dermatology, transplants, and biomanufacturing areas. The company was formerly known as RJV Network, Inc. and changed its name to ProtoKinetix, Incorporated in July 2003. ProtoKinetix, Incorporated was incorporated in 1999 and is based in Dalton, Ohio.

Peers in Healthcare

ProtoKinetix, Incorporated has no peer companies in this window.

Recent press releases

ProtoKinetix, Incorporated has not issued a press release in this window.

SEC filings

All filings →

ProtoKinetix, Incorporated has not filed an SEC document in this window.

ProtoKinetix, Incorporated has no reported insider trades in the last 90 days.

Institutional holders

All holders →
As of 2025-12-31 · prior 2025-09-30

People at ProtoKinetix, Incorporated

All people →

No officers or directors have been indexed for ProtoKinetix, Incorporated.

Quarterly financials

Full financials →
Revenue trend
03/25
—
NI -$97.7K
06/25
—
NI -$91.1K
09/25
—
NI -$84.9K
RevenueNI = Net Income
EPS trend (diluted)
Latest: $0.00
Prior: $0.00
Revenue sparkline